sch 58261 has been researched along with 3-n-butylphthalide in 1 studies
| Studies (sch 58261) | Trials (sch 58261) | Recent Studies (post-2010) (sch 58261) | Studies (3-n-butylphthalide) | Trials (3-n-butylphthalide) | Recent Studies (post-2010) (3-n-butylphthalide) |
|---|---|---|---|---|---|
| 46 | 0 | 14 | 350 | 23 | 282 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; Cai, H; Ge, J; He, X; Xie, T; Yao, C; Ye, XY; Zhong, Z; Zhu, J | 1 |
1 review(s) available for sch 58261 and 3-n-butylphthalide
| Article | Year |
|---|---|
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification.
Topics: Biological Products; Blood-Brain Barrier; Dopaminergic Neurons; Humans; Neurodegenerative Diseases; Parkinson Disease | 2022 |